SkinHealth Systems Inc. (SKIN) Stock Price & Analysis
SkinHealth Systems Inc. (SKIN) closed at USD 12.6 on Thursday, October 15, 2026, up 9.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 11.56; the Oct 15, 2026 session ranged USD 10.71–12.89 on volume of 63,472 shares. Market capitalization is $81.99M, with a 52-week range of USD 10.01–34.8 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SKIN.md
Key facts (SKIN)
- Analysts: Hold (mean 3.33 on a 1–5 scale) (9 analysts), mean target USD 18.17 (range 10–30).
- Total return with dividends: 1Y +775.0% vs S&P 500 +18.1%; 5Y -50.8% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD 0, revenue estimate $67.9M.
Analysts (SKIN)
Consensus Hold (mean 3.33 on a 1–5 scale), 9 analysts; mean target USD 18.17 (low 10, high 30).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-12 | TD Cowen | Target lowered | Hold | $1 → $0.9 |
Total return (dividends reinvested) (SKIN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | +775.0% | -50.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +781.5% | -13.2% |
| Volatility (annualized) | 331.0% | 162.7% |
| Max drawdown | -65.4% (Dec 2025→Oct 2026) | -98.1% (Nov 2021→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:22 UTC)
| Price | USD 12.6 |
|---|---|
| Change | ▲ 9.00% (up) |
| Previous Close | USD 11.56 |
| Open | USD 11.31 |
| Day Range | USD 10.71 – 12.89 |
| 52-Week Range | USD 10.01 – 34.8 |
| Volume | 63,472 shares |
| Market Cap | $81.99M |
| Exchange | NCM |
Technical Analysis (SKIN)
Nexqual's technical model rates SKIN "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of October 16, 2026 at 05:22 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 98.97 (overbought) |
| vs SMA50 | Above (USD 0.9) |
| MACD | 0.93 (positive) |
Analyst Ratings (SKIN)
Wall Street analysts rate SKIN "Hold" based on 9 analysts, with a mean price target of USD 18.17 (range USD 10–30), per Nexqual as of October 16, 2026 at 05:22 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 9 |
| Mean Target | USD 18.17 |
| High Target | USD 30 |
| Low Target | USD 10 |
| Buy / Hold / Sell | 1 / 6 / 2 |
Earnings (SKIN)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 0 |
| Revenue Estimate | $67.93M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -1.2 vs est -1.09 ▼ miss |
| 2025-09-30 | USD 0.57 vs est -1 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financials & Fundamentals (SKIN)
| Total Revenue | $290.05M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -7.80% |
| Gross Margin | +66.35% |
| Operating Margin | +4.95% |
| Profit Margin | -9.80% |
| ROE | -43.89% |
| Debt / Equity | 6.61 |
| Current Ratio | 1.76 |
| Total Cash | $204.07M |
| Total Debt | $367.04M |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Financial Health Score (SKIN)
Nexqual rates SkinHealth Systems Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:22 UTC.
| Growth | Critical — Revenue -10% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 66%, operating 5% |
| Balance Sheet | Critical — $204M cash vs $367M debt |
| Cash Flow | Solid — Operating cash flow $22M (TTM) |
| Efficiency | Critical — ROE -44%, ROA -0.5% |
Ownership (SKIN)
| Insider Ownership | +12.89% |
|---|---|
| Institutional Ownership | +77.17% |
| Shares Outstanding | 6.51M |
| Float | 2.55M |
| Short % of Float | +15.35% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Leadership (SKIN)
SkinHealth Systems Inc. is led by Pedro Malha (age 53), CEO, President & Director, per Nexqual as of October 16, 2026 at 05:22 UTC.
| CEO, President & Director | Pedro Malha (age 53) |
|---|---|
| Chief Financial & Operating Officer | Michael P. Monahan (age 53) |
| Senior Vice President of International | Tanja Wirtz |
| Senior Vice President of Americas | Kelly Pennington |
Major Backers & Investors (SKIN)
Notable institutional backers of SkinHealth Systems Inc. include Capricorn Fund Managers Ltd, FMR, LLC, Millennium Management, according to Nexqual as of October 16, 2026 at 05:22 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capricorn Fund Managers Ltd | 0.86% |
| FMR, LLC | 0.39% |
| Millennium Management | 0.29% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 0.33% |
| Vanguard Group | 0.33% |
Source: Nexqual, October 16, 2026 at 05:22 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MAGN | Magnera Corporation | USD 11.25 | ▲ 1.44% |
| HNST | The Honest Company, Inc. | USD 5.12 | ▼ 1.35% |
| HELE | Helen of Troy Limited | USD 29.53 | ▲ 6.15% |
| ODD | ODDITY Tech Ltd. | USD 23.17 | ▲ 4.75% |
| EPC | Edgewell Personal Care Company | USD 28.1 | ▼ 1.51% |
| SPB | Spectrum Brands Holdings, Inc. | USD 78.91 | ▲ 2.24% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt